Effects of glucose‐lowering agents on cardiovascular and renal outcomes in subjects with type 2 diabetes: An updated meta‐analysis of randomized controlled trials with external adjudication of events-Reference-Cited by-同舟云学术

Effects of glucose‐lowering agents on cardiovascular and renal outcomes in subjects with type 2 diabetes: An updated meta‐analysis of randomized controlled trials with external adjudication of events

Published:2022-10-24 Issue:2 Volume:25 Page:444-453
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:Diabetes Obesity Metabolism

Author:

Mannucci Edoardo¹^ORCID,Gallo Marco²,Giaccari Andrea³^ORCID,Candido Riccardo⁴,Pintaudi Basilio⁵,Targher Giovanni⁶^ORCID,Monami Matteo¹^ORCID,

Affiliation:

1. Diabetology Careggi Hospital and University of Florence Firenze Italy

2. Endocrinology and Metabolic Diseases Unit, AO SS. Antonio e Biagio e Cesare Arrigo Alessandria Italy

3. Centro per le Malattie Endocrine e Metaboliche Fondazione Policlinico Universitario A. Gemelli UCSC and Università cattolica del Sacro Cuore Rome Italy

4. Diabetes Center Azienda Sanitaria Unversitaria Giuliano Isontina Trieste Italy

5. Diabetes Center ASST Niguarda Hospital Milan Italy

6. Section of Endocrinology, Diabetes and Metabolism, Department of Medicine University of Verona Verona Italy

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/dom.14888

Reference70 articles.

1. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study

2. Prevention of cardiovascular disease through glycemic control in type 2 diabetes: A meta-analysis of randomized clinical trials

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Age‐ and gender‐adjusted estimated glomerular filtration rate definition reveals hyperfiltration as a risk factor for renal function deterioration in type 2 diabetes;Diabetes, Obesity and Metabolism;2024-02

2. Some patients with type 2 diabetes may benefit from intensive glycaemic and blood pressure control: A post‐hoc machine learning analysis of ACCORD trial data;Diabetes, Obesity and Metabolism;2024-01-31

3. Treatment of type 2 diabetes;Die Diabetologie;2024-01-30

4. Albuminuria: An Underappreciated Risk Factor for Cardiovascular Disease;Journal of the American Heart Association;2024-01-16

5. Applications of Clinical Decision Support Systems in Diabetes Care: Scoping Review;Journal of Medical Internet Research;2023-12-08